FBRX Strangle Strategy
FBRX (Forte Biosciences, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
FBRX (Forte Biosciences, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $342.4M, a beta of 3.00 versus the broader market, a 52-week range of 7-35.8, average daily share volume of 283K, a public-listing history dating back to 2017, approximately 14 full-time employees. These structural characteristics shape how FBRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 3.00 indicates FBRX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on FBRX?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current FBRX snapshot
As of May 15, 2026, spot at $23.06, ATM IV 228.40%, IV rank 39.41%, expected move 65.48%. The strangle on FBRX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on FBRX specifically: FBRX IV at 228.40% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 65.48% (roughly $15.10 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated FBRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on FBRX should anchor to the underlying notional of $23.06 per share and to the trader's directional view on FBRX stock.
FBRX strangle setup
The FBRX strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With FBRX near $23.06, the first option leg uses a $24.21 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed FBRX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 FBRX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $24.21 | N/A |
| Buy 1 | Put | $21.91 | N/A |
FBRX strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
FBRX strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on FBRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on FBRX
Strangles on FBRX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the FBRX chain.
FBRX thesis for this strangle
The market-implied 1-standard-deviation range for FBRX extends from approximately $7.96 on the downside to $38.16 on the upside. A FBRX long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current FBRX IV rank near 39.41% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on FBRX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, FBRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to FBRX-specific events.
FBRX strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. FBRX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move FBRX alongside the broader basket even when FBRX-specific fundamentals are unchanged. Always rebuild the position from current FBRX chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on FBRX?
- A strangle on FBRX is the strangle strategy applied to FBRX (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With FBRX stock trading near $23.06, the strikes shown on this page are snapped to the nearest listed FBRX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are FBRX strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the FBRX strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 228.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a FBRX strangle?
- The breakeven for the FBRX strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current FBRX market-implied 1-standard-deviation expected move is approximately 65.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on FBRX?
- Strangles on FBRX are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the FBRX chain.
- How does current FBRX implied volatility affect this strangle?
- FBRX ATM IV is at 228.40% with IV rank near 39.41%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.